FindTrial
Sign In

Study on Growth Hormone Deficiency

Diagnostic Utility of the ratio of Serum Insulin like Growth Factor-1 to its Serum Binding Protein-3 in Growth Hormone Deficiency in comparison to Clonidine Stimulation Test - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084660
Enrollment
100
Registered
2025-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E343- Short stature due to endocrine disorder

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

KLE Academy of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Children between 4-16years presenting to Paediatric and Paediatric Endocrinology OPD with Short Stature fulfilling the Clinical and/or Auxological criteria for Growth Hormone Deficiency

Exclusion criteria

Exclusion criteria: Syndromic Short Stature Chronic Organic illness, Chronic Anaemia, Malnutrition, Chronic kidney disease, chronic liver disorders, Congenital Heart Disease Skeletal Dysplasia or other disorders of bone mineralization Untreated Hypothyroidism , Hypogonadism, Multiple Pituitary Hormone Deficiency

Design outcomes

Primary

MeasureTime frame
To analyse serum IGF1 to serum IGFBP3 ratio in diagnosis of Growth Hormone Deficiency Timepoint: At Baseline—

Secondary

MeasureTime frame
To study diagnostic utility of Serum IGF1 in Growth Hormone Deficiency To study diagnostic utility of Serum IGFBP3 in Growth Hormone Deficiency To study diagnostic utility of Serum IGF1 to Serum IGFBP3 ratio in combination with Serum IGF1 & Serum IGFBP3 in Growth Hormone Deficiency Timepoint: At Baseline—

Countries

India

Contacts

Public ContactMeenakshi B Ramanna

Jawaharlal Nehru Medical College, KLE University, Belagavi

meenakshi.br@gmail.com9900184188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026